Results 21 to 30 of about 47,789 (269)

Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab

Emerging Infectious Diseases, 2018
Patients receiving eculizumab have an increased risk for meningococcal disease, but most reported cases are attributable to encapsulated meningococcal strains.
Deirdre Nolfi-Donegan, Monica Konar, Vianca Vianzon, Jessica MacNeil, James Cooper, Perrianne Lurie, Judi Sedivy, Xin Wang, Dan M. Granoff, Lucy McNamara   +9 more
doaj   +1 more source

What is the evidence for giving chemoprophylaxis to children or students attending the same preschool, school or college as a case of meningococcal disease? [PDF]

, 2011
We performed a systematic literature review to assess the effectiveness of chemoprophylaxis for contacts of sporadic cases of invasive meningococcal disease (IMD) in educational settings.
Ackerman, Barker, Bernabeu, Cartwright, Davison, Dawson, Favorova, Ferson, Fraser, G. HANQUET, Giovanetti, González de Aledo, Granerod, Hastings, Hoek, J. M. STUART, Jacobson, Juels, Norton, O'Donovan, P. STEFANOFF, Palau, Riordan, Robinson, S. HEUBERGER, S. NIELSEN, Scholten, Schubiger, Stefanoff, Sutton, W. HELLENBRAND   +30 more
core   +2 more sources

Population-based study of influenza and invasive meningococcal disease among Greek children during the COVID-19 pandemic

BMJ Paediatrics Open, 2022
Background Aiming to the containment of the coronavirus disease 2019 (COVID-19) pandemic, governments worldwide have implemented a series of non-pharmaceutical interventions.
Theoklis Zaoutis, Vassiliki Papaevangelou, Danai Ktena, Eleni Kourkouni, Flora Kontopidou, Kassiani Gkolfinopoulou, Kalliopi Papadima, Theano Georgakopoulou, Ioanna Magaziotou, Anastasia Andreopoulou, Georgina Tzanakaki   +10 more
doaj   +1 more source

Preventing invasive meningococcal disease in early infancy

Human Vaccines & Immunotherapeutics, 2022
This review considers the pathogenesis, diagnosis, and epidemiology of invasive meningococcal disease in infants, to examine and critique meningococcal disease prevention in this population through vaccination.
Jessica Presa, Lidia Serra, Catherine Weil-Olivier, Laura York   +3 more
doaj   +1 more source

Invasive meningococcal disease in the Veneto region of Italy: A capture-recapture analysis for assessing the effectiveness of an integrated surveillance system [PDF]

, 2017
open8noBACKGROUND: Epidemiology of Neisseria meningitidis has been changing since the introduction of universal vaccination programmes against meningococcal serogroup C (MenC) and meningococcal serogroup B (MenB) has now become dominant.
Baldo, Vincenzo, Baldovin, Tatjana, Bertoncello, Chiara, Cocchio, Silvia, Furlan, Patrizia, Lazzari, Roberta, Russo, Francesca, Saia, Mario   +7 more
core   +1 more source

Invasive meningococcal disease [PDF]

Arquivos de Neuro-Psiquiatria, 2013
Invasive meningococcal disease (IMD) is a major public health and continues to cause substantial mortality and morbidity. Serotype C is the most frequent in Brazil. The clinical spectrum of IMD is broad (meningitis, meningococcemia or both) and the clinical evolution may be unpredictable.
Strelow, Vanessa L., Vidal, Jose E.
openaire   +6 more sources

Cocirculation of Hajj and non-Hajj strains among serogroup W meningococci in Italy, 2000 to 2016 [PDF]

, 2019
In Italy, B and C are the predominant serogroups among meningococci causing invasive diseases. Nevertheless, in the period from 2013 to 2016, an increase in serogroup W Neisseria meningitidis (MenW) was observed.
Arghittu M., Barbui A. M., Bernaschi P., Bisbano A., Chironna M., Ciammaruconi A., De Nittis R., Fazio C., Galanti I. A., Giammanco A., Isola P., Mencacci A., Neri A., Pagani E., Stefanelli P., Vacca P., Vocale C.   +16 more
core   +1 more source

Dramatic decline of serogrup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people [PDF]

, 2001
STUDY OBJECTIVES The objective of this study was to evaluate the effectiveness of a mass vaccination programme carried out in Catalonia (Spain) in the last quarter of 1997 in response to an upsurge of serogroup C meningococcal disease (SCMD).
Domínguez García, Àngela, Muñoz, Pilar, Parrón Bernabé, Ignacio, Prats, Guillem, 1942-, Salleras i Sanmartí, Lluís   +4 more
core   +2 more sources

Bacterial outer membrane vesicles and vaccine applications [PDF]

, 2014
Vaccines based on outer membrane vesicles (OMV) were developed more than 20 years ago against Neisseria meningitidis serogroup B. These nano-sized structures exhibit remarkable potential for immunomodulation of immune responses and delivery of “self ...
Acevedo, Reinaldo, Acosta, Armando, Campa, Concepcion, Cardoso, Daniel, Fernandez, Sonsire, Ferro, Valerie, Garcia, Luis, Perez, Jose Luis, Rosenqvist, Einar, Sarmiento, Maria Elena, Zayas, Caridad   +10 more
core   +2 more sources

Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp. [PDF]

, 1996
Serogroup A meningococcus epidemics occurred in refugee populations in Zaire in August 1994. The paper analyses the public health impact of a mass vaccination campaign implemented in a large refugee camp.
Blok, L, Boelaert, M, Haelterman, E, Henkens, M, Suetens, C, Toole, M J   +5 more
core   +2 more sources